Skip to main content
Diabetes Care logoLink to Diabetes Care
. 2022 Oct 13;45(12):3112. doi: 10.2337/dc22-er12

Erratum. Effects of Cotadutide on Metabolic and Hepatic Parameters in Adults With Overweight or Obesity and Type 2 Diabetes: A 54-Week Randomized Phase 2b Study. Diabetes Care 2021;44:1433–1442

Rajaa Nahra, Tao Wang, Kishore M Gadde, Jan Oscarsson, Michael Stumvoll, Lutz Jermutus, Boaz Hirshberg, Philip Ambery
PMCID: PMC9763024  PMID: 36228195

In the article cited above, the y axis in Fig. 3C was incorrectly labeled “% Change in FIB-4 Index.” The correct label is “Mean change in FIB-4 index.” Figure 3C and its corresponding legend text have been amended accordingly.

In addition, the legend text for Fig. 3D did not match the data reported. Panel D represents mean change, not percent change, in NAFLD fibrosis score (NFS). The legend text has been corrected to read “D: Mean change in NFS.”

As a result of these changes, the title of Fig. 3 has been amended from “Percent change in hepatic parameters from baseline to week 54” to “Change in hepatic parameters from baseline to week 54.”

The authors apologize for the errors.

The online version of the article (https://doi.org/10.2337/dc20-2151) has been updated to correct the errors.


Articles from Diabetes Care are provided here courtesy of American Diabetes Association

RESOURCES